The quarterly plan of implementation of the activities outlined in the CBMM Strategy is provided in the Table below.
|
Year 1
|
Year 2
|
Year 3
|
Year 4
|
Year 5
|
|
Q
1
|
Q
2
|
Q
3
|
Q
4
|
Q
1
|
Q
2
|
Q
3
|
Q
4
|
Q
1
|
Q
2
|
Q
3
|
Q
4
|
Q
1
|
Q
2
|
Q
3
|
Q
4
|
Q
1
|
Q
2
|
Q
3
|
Q
4
|
Programme planning and management
|
|
Writing TORs for malaria CBMM coordinator
|
X
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Appoint malaria CBMM
Coordinator
|
X
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Development of Guidelines
|
|
Case management of fever
|
X
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fever management algorithms
|
X
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
RDT quality assurance at point of care
|
X
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
RDT transport and storage methods
|
X
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Develop IEC materials
|
X
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
RDT procurement and logistics
|
|
RDT, gloves, sharp boxes procurement
|
X
|
|
|
|
X
|
|
|
|
X
|
|
|
|
X
|
|
|
|
X
|
|
|
|
Receive RDTs (staggered delivery)
|
X
|
|
X
|
|
X
|
|
X
|
|
X
|
|
X
|
|
X
|
|
X
|
|
X
|
|
X
|
|
Distribution of RDT and other supplies to the field
|
|
X
|
|
X
|
|
X
|
|
X
|
|
X
|
|
X
|
|
X
|
|
X
|
|
X
|
|
X
|
ACT procurement and logistics
|
|
ACT procurement
|
X
|
|
|
|
X
|
|
|
|
X
|
|
|
|
X
|
|
|
|
X
|
|
|
|
Receive ACTs (staggered delivery)
|
X
|
|
X
|
|
X
|
|
X
|
|
X
|
|
X
|
|
X
|
|
X
|
|
X
|
|
X
|
|
Distribution of ACTs to the field
|
|
X
|
|
X
|
|
X
|
|
X
|
|
X
|
|
X
|
|
X
|
|
X
|
|
X
|
|
X
|
RDT Quality Assurance
|
|
Write SOPs and Job Aids for RDTs
|
X
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
RDT Post-shipment lot-testing (as appropriate)
|
X
|
|
|
|
X
|
|
|
|
X
|
|
|
|
X
|
|
|
|
X
|
|
|
|
Training
|
|
Develop training tools for RDTs and ACTs
|
X
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Develop training tools for supervisors
|
X
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Conduct Training of Trainers courses
|
|
X
|
|
|
|
X
|
|
|
|
X
|
|
|
|
X
|
|
|
|
X
|
|
|
Training of health workers and supervisors
|
|
X
|
X
|
|
|
X
|
X
|
|
|
X
|
X
|
|
|
X
|
X
|
|
|
X
|
X
|
|
Communication
|
|
Community sensitization
|
|
|
X
|
X
|
X
|
X
|
X
|
X
|
X
|
X
|
X
|
X
|
X
|
X
|
X
|
X
|
X
|
X
|
X
|
X
|
Supervision
|
|
Regular supervision
|
|
|
X
|
X
|
X
|
X
|
X
|
X
|
X
|
X
|
X
|
X
|
X
|
X
|
X
|
X
|
X
|
X
|
X
|
X
|
Monitoring and evaluation
|
|
Review record forms and procedures
|
X
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Monitoring outcome indicators
|
|
|
X
|
X
|
X
|
X
|
X
|
X
|
X
|
X
|
X
|
X
|
X
|
X
|
X
|
X
|
X
|
X
|
X
|
X
|
Operational Research
|
|
Introduction of RDTs in DH and CBC
|
|
|
|
|
X
|
X
|
X
|
X
|
|
|
|
|
|
|
|
|
|
|
|
|
Evaluating incentive schemes for CHWs
|
|
|
|
|
|
|
|
|
X
|
X
|
X
|
X
|
|
|
|
|
|
|
|
|
Malaria treatment seeking behaviour
|
|
|
|
|
|
|
|
|
|
|
|
|
X
|
X
|
X
|
X
|
|
|
|
|
ANNEX 6 Budget components and financial gaps (USD)
The annual budget (in USD) for the main activities outlined in the CBMM Strategy are presented in the Table below. Funding for commodities which are already supplied by BPSH are not included, i.e. for the procurement and distribution of chloroquine, primaquine and antibiotics for the management of non-malaria fevers of bacterial origin. The funding gap has been calculated only for years 1 and 2, in view of the firm commitment from the GFR8.
Activity
|
Year 1
|
Year 2
|
Year 3
|
Year 4
|
Year 5
|
Development of Guidelines
|
|
Guidelines for RDT transport and storage
|
10,000
|
|
|
|
|
Fever management algorithm
|
5,000
|
|
|
|
|
Supervision checklists and temp. charts
|
5,000
|
|
|
|
|
RDT procurement and supply management
|
|
RDT, gloves, sharp boxes procurement
|
111,350
|
171,982
|
284,228
|
389,978
|
389,978
|
Distribution of RDT and other supplies to the field (10%)
|
11,135
|
17,198
|
28,423
|
38,998
|
38,998
|
ACT procurement and supply management
|
|
ACT procurement
|
11,329
|
17,497
|
28,918
|
39,677
|
39,677
|
Distribution of ACTs to the field (10%)
|
1,133
|
1,750
|
2,892
|
3,968
|
3,968
|
RDT Quality Assurance
|
|
Post-shipment lot-testing of RDTs (as appropriate)
|
100
|
100
|
|
|
|
Training
|
|
Instructions and training manual for supervisors
|
5'000
|
|
|
|
|
Training of trainers
|
4,620
|
36,805
|
42,644
|
26,991
|
26,991
|
Training of health workers
|
4,896
|
42,982
|
42,670
|
32,559
|
31,452
|
Training of supervisors
|
574
|
4,563
|
5,286
|
3,346
|
3,346
|
Communication
|
|
Community sensitization
(health forum)
|
3,000
|
129,300
|
129,300
|
221,680
|
221,680
|
Supervision
|
|
Regular supervision
|
4,920
|
38,880
|
12,660
|
29,880
|
44,220
|
Monitoring and evaluation
|
|
Develop record forms, survey procedures
|
10,000
|
|
|
|
|
Health facility survey for outcome indicators
|
5,000
|
5,000
|
5,000
|
5,000
|
5,000
|
OR: introduction of RDTs in DH and CBC
|
|
20,000
|
|
|
|
OR: evaluating incentive schemes for CHWs
|
|
|
25,000
|
|
|
OR: malaria treatment seeking behaviour
|
|
|
|
20'000
|
|
TOTAL
FUNDS REQUIRED
|
188,057
|
486,056
|
607,021
|
792,077
|
805,310
|
BUDGET AVAILABLE
(R8 GF malaria)*
|
392,573
|
656,528
|
551,610
|
565,313
|
579,701
|
FINANCIAL GAP
|
-204,516
|
-170,472
|
55,411
|
226,764
|
225,609
|
* calculated from approved funding Global Fund R8 malaria grant
The total core budget required to implement the 5 years strategy is USD 2,878,521. Considering the total funding available to implement the GF R8 grant, amounting to USD 2,745,725 the funding gap amounts to USD 132,796 for the 5 years implementation of the CBMM Strategy.
ANNEX 7: CBMM training Curriculum
Contents
Background
Introduction of CBMM
What is CBMM
What CBMM offers
Why CBMM
CBMM providers
Components of CBMM
Why CHW training on CBMM
Necessity of the curriculum
Contents of the curriculum
Chapter one:
General information about malaria
What is malaria
Signs & symptoms of malaria
Causative agents of malaria
Vector of malaria
Mode of transmission of malaria
Diagnosis of malaria
Prevention of malaria
Chapter two:
Introduction of RDT
What is RDT
Advantage and disadvantage of RDT
Procedure of RDT use
Storage of RDT
Chapter three:
Practical use of RDT
Technique of blood collection from patient’s finger
Use of RDT for malaria diagnosis
Interpretation of the result of RDT
Chapter four:
Treatment of malaria
Introduction of ACT
Treatment of malaria by using ACT
flow chart of Malaria treatment
Chapter five:
Sessions of the training
Objective of the session
Methods of lesson
Topic of the session
Materials
Annex
Annex a - Instructions for the training
Annex b – Training schedule
Annex c- Pre-test
Annex d- Post-test
Annex e- pictorial instruction for RDT use
Annex f- Malaria Treatment Dosage Chart
Annex g- RDT follow up tally sheet
Annex h- RDT monthly Aggregated report
Annex i- ACT use tally sheet
Annex j- Monthly report on ACT use
Annex k - Referral form
Background
Malaria is an endemic disease and a major public health problem in many Provinces of Afghanistan. It causes a great burden on the health and economic development of individuals, families and communities living in endemic areas. The total number of reported malaria cases were 427,743 1n 2006, 390729 in 2009 and 390121 in 2010. Majority of these cases were clinically diagnosed: 79.77%, 83.40% and 80.04% respectively(HMIS 2010). The Government of Afghanistan remains committed to the control of this disease. For this purpose the Government developed the National Malaria Strategy Plan 2008-2013 with a vision of a malaria free Afghanistan. Two priority targets mentioned in NMSP 2008-2013 include:
By the end of 2013, 60% of targeted Health Posts will be able to diagnose malaria by RDTs
By the end of 2009, in order to strengthen malaria control at the community level, the NMLCP and all PMLCPs will have a Community-Based Component including Home Management of Malaria (CBMM)
Introduction of CBMM-
What is CBMM (Community Based Management of Malaria)
It is a care delivery strategy at community level to diagnose and provide effective treatment for uncomplicated plasmodium falciparum malaria which will reduce the burden of morbidity and mortality due to malaria in endemic areas.
What CBMM offers?
At present at health post level CHWs have Sulfadoxine Pyrimethamine and Chloroquine in their kit to treat malaria. CHWs are treating malaria without any confirmed diagnosis. CBMM approach will include RDTs and ACTs in their kits along with SP and Chloroquine. RDTs will be used for rapid diagnosis of malaria and ACTs will be used to treat confirm uncomplicated falciparum malaria cases.
Why CBMM?
The Government of Afghanistan is committed to provide health care services to the entire nation to improve the health condition of the people. But unfortunately in some geographical areas communities are remotely located from the health facilities limiting access to health services. During 2010, 31,2267 malaria cases were clinically diagnosed throughout Afghanistan from which 137,670 cases i.e. 40.08% were clinically diagnosed at health post level. Therefore CBMM will play a pivotal role in confirming malaria diagnosis at health post level up to households. This will limit the excess use of Chloroquine & SP as well as prevent resistance (plasmodium falciparum) to Sulfadoxine Pyrimethamine. In addition to the treatment, CHWs will be able to differentiate the severe cases and refer to health facilities for proper management. This strategy will assist weak health care systems, where women and children cannot reach health facilities and where self-treatment is common and often misguided.
CBMM providers:
Community Health Workers will provide specific health care services (diagnosis using RDT and treatment via ACT) at health post level.
Community Health Supervisors will monitor and supervise activities of the CHWs
Component of CBMM
Diagnosis of malaria by using RDT test
Treatment of uncomplicated Plasmodium falciparum malaria by ACT
Why CHWs training on CBMM?
A health post operates as a basic health service is delivered by the CHW. This grassroots level health service delivery point is ideally staffed by one male and one female CHW. CHWs provide care to an average of 27% of the total number of outpatients visiting the health facilities (2008). The numbers of outpatients have increased with the expansion of health posts as a result of which over the past two years, the numbers seen per health post have increased by 50%. Unlike health facilities, there is no decline in visits during the winter months, 40% - 45% of childhood illnesses are managed by CHWs. (CBHC Policy and Strategy, Page 9), highlighting the importance trained CHWs contributes towards malaria diagnosis and treatment at community level.
Why this curriculum?
This curriculum is developed for training CHWs & CHS on CBMM. As mentioned above the Government of Afghanistan is committed to control malaria in Afghanistan. Introduction of RDTs for early diagnosis of malaria and establishment of CBMM at community level are key interventions that will reduce morbidity and mortality of malaria. This curriculum will help to enhance their knowledge about malaria as well as it will build their confidence to introduce RDT for early diagnosis and ACT for treatment of falciparum malaria at community level.
Chapter one:
General information about malaria & approach to a malaria suspected patient
What is malaria-
Malaria is a vector borne parasitic febrile communicable disease.
Symptoms of malaria
The main symptom is fever
Fever may result in chills
Fever appears at the same time of the day
Fever disappears with sweating
After the disappearance of fever individual feels well/ healthy
Other signs and symptoms of malaria are:
Headache
Joint and body pain
Shivering
Vomiting
Diarrhoea (especially in children)
Causative agent of malaria:
Malaria is caused by a parasite called Plasmodium. There are four main types of Plasmodium. These are-
Plasmodium falciparum (Pf)
Plasmodium vivax (Pv)
Plasmodium malariae (Pm)
Plasmodium ovale (Po)
In Afghanistan Pv is more prevalent than Pf
Vector of malaria:
Female anopheles mosquito is the vector of malaria
Mode of transmission:
Female anopheles bites a malarial patient and gets Plasmodium with blood
This infected mosquito bites a healthy individual and introduces Plasmodium into the blood.
Malaria undergoes a sexual cycle inside the infected individuals
After a period of time the healthy individual suffers from malaria
Figure: Mode of transmission of malaria Diagnosis of malaria: malaria can be diagnosed
Clinically
By microscopic examination of blood of the suspected person
By using RDT (Rapid Diagnostic Test)
Prevention of malaria: There are three main ways in which we try to reduce the spread of malaria:
Treat people who are sick with malaria quickly so that the microorganisms cannot be sucked up by a mosquito,
Reduce the numbers of mosquitoes by controlling their breeding sites, and
Preventing mosquito bites by using bed nets with insecticide.
The most effective method is the use of long lasting insecticidal nets.
Approach to the patient:
Step 1. Register the patient. If the CHW is illiterate the family member or patient or patient’s family member will help to register the patient.
Step 2. Please follow the procedures
ASK about : ( ask the patient or guardian in case of children)
The chief complaints: fever, headache, earache, throat pain, chilling, vomiting, cough, breathing difficulties, burning micturition.
Present illness: explanation of the above symptoms eg patient complains of fever and CHW must enquire after the fever history
Past history of the complaints: History of body feeling hot within 2-3 days, duration of the symptoms
History of past illness: history of past episode of fever, malaria etc
LOOK:
Observe the appearance- ill looking/ unconsciousness/ drowsiness/ stable
FEEL:
Use the back of your palm to check if the patient’s forehead feels hot
Inspect the patient for : (more emphasise in case of children)
Ear discharge ( ask about ear pain)
Infection of the skin
Fast breathing / breathing difficulties
Sore throat ( ask about throat pain)
TEST
Measure body temperature with thermometer from armpit (≥37.5°C/99.5° F or above) if the patient has fever
Use RDT (if needed)
Action to be taken By CHW:
If the patient’s symptoms are similar to that of malaria and his/her condition is stable without any danger sign, use RDT. Treat the patient with ACT or Chloroquine if the result is positive for the malaria test. Give the first dose instantly.
Refer the patient with danger signs to the nearest health facility.
The danger signs are:
He/she is uunable/unwilling to drink or feed (breastfeeding for children)
He/she vomits everything
History of convulsions
Presence of Lethargy / drowsiness / unconsciousness
she is severely anaemic
Refer the patient of less than 5 months age with RDT positive result to the nearest health facility.
Refer the pregnant women (1st trimester) with RDT positive result to the nearest health facility.
N.B. Please follow the malaria flow chart and treatment guideline.
Chapter Two
Introduction of RDT
What is RDT (Rapid Diagnostic Test)
RDT is a malaria diagnostic device that detects malaria specific protein (antigens) which is produced by malaria parasites.
It has
Space A for buffer
Space S for blood sample
Window C for control
Window test for Pf or PAN (Plasmodium another- P. vivax, or P. malaria or P. ovale) result
Advantages of RDT:
No need for laboratory facilities
Easy to carry
Simplicity and rapidity of the tests.
No need for electricity or laboratory equipment.
Minimal requirement for training (basic skills acquired in 1 day).
Acceptable levels of sensitivity and specificity, and
Disadvantages of RDT:
More expensive than microscopy.
Prolonged positive result after effective treatment.
Storage conditions of RDTs
Procedure of RDT use:
1-Prepare the materials needed
RDT
new, unopened lancet
Alcohol swab
disposable gloves
timer or watch
Safety box
Pencil or marker for labeling the RDT
Record book and pen for results
Take time to explain briefly to the patient what you are going to do
2- Check
- Expiration date of the RDT
- Colour of desiccant
DO NOT use expired damaged RDT or if there is a sign of exposure to humidity!
3- Wear disposable gloves.
Doing the test (1)
Open the RDT packet and take out device just before use
Label RDT with patient’s name or ID before doing the test
Clean the patient’s finger with an alcohol swab and let it dry before doing a finger prick
Discard used lancet immediately in the safety box
Touch the surface of the blood with the collecting tube/device to get 5mL of blood
DO NOT collect too much blood as this may affect the test result
6) Slowly deliver the blood from the collecting tube onto the sample wall (S)
7) Discard the used blood collecting tube immediately in the sharp box
8) Invert the buffer bottle vertically and slowly dispense the required number of
drops into the buffer well (A)
9) Wait for the prescribed time (e.g.15-20 minutes) before reading the results
Storage of RDT:
Keep RDTs in the coolest part of the room, but never freeze them. They do not need refrigeration
Protect RDTs from excessive heat (Keep it within 40-300 C)
Store away from direct sunlight
Do not store close to a wall or ceiling, as both absorb heat during the day
Store a minimum of 30 cm away from walls and ceiling
Do not store directly on the ground
To reduce damage from moisture, water, and pests, store on a shelving unit or shelf, if possible
Chapter Three:
Practical use of RDT
Technique of the blood collection:
Take alcohol swab and clean the patient’s finger
Let it dry before the pricking
Open the lancet
Prick the finger with lancet
Discard the lancet in to the sharp box
Swab the first drop of blood
Press the pricked finger for second drop of blood
Touch the surface of the blood with the collecting tube to get 5mL of blood
Slowly deliver the blood from the collecting tube on to the sample wall (S)
Discard the used blood collecting tube immediately in the safety box
Practical use of RDT:
Participants will follow the instruction of RDT use (mentioned above)
They will follow the given Pictorial procedure of RDT use
They will apply on patients
Otherwise they will form groups and do the practical on each other.
Interpretation of the result:
Invalid result (the test device is invalid):
No line in the control window or
No line in the control & test window
Picture of RDTs with result mentioned above
Valid result( the test device is valid):
Red line only in the control window or
Red line in the control & test window
Picture of RDTs with result mentioned above
Red line in the control window and
No line in the test window
Picture of RDTs with result mentioned above
Red line in the control window and
Red line in the test window
Picture of RDTs with result mentioned above
Interpretation of positive result:
Red line in control window & in Pf line of test window – Pf malaria case
Red line in control window & in PAN line of test window – Pv malaria case
Red line in control window , in Pf line & PAN line of test window – mix infection
Picture of RDTs with result mentioned above
After doing the test
1) Discard used gloves, swab, and desiccant in a non-sharp waste container
2) Keep used RDTs in the box. Return used RDTs for replacement with new RDTs
3) Record results in the register.
Chapter Four:
Treatment of malaria
What is ACT:
ACT - it is artemisinin combination therapy. It includes Artesunate 50/100mg + SP (sulfadoxine500 mg +Pyrimathamine 25 mg).
Treatment of P. falciparum malaria:
Artesunate(50 mg or 100 mg ) and SP( sulfadoxine500 mg +Pyrimathamine 25 mg) the recommended drugs for effective malaria treatment in Afghanistan
Dosage Chart
|
First Day
|
Second day
|
Third day
|
Remarks
|
Age
|
SP
|
Artesunate
|
Artesunate
|
Artesunate
|
5-11 months
|
Half tablet
|
Half tablet
Of 50 mg
|
Half tablet
|
Half tablet
|
Child
blister
|
1-6 years
|
One tablet
|
One tablet
Of 50 mg
|
One tablet
|
One tablet
|
7-13 years
|
Two tablets
|
Two tablets
Of 50 mg
|
Two tablets
|
Two tablets
|
Above 13 years
|
Three tablets
|
Two tablets
Of 100 mg
|
Two tablets
|
Two tablets
|
Adult blister
|
Important;
Day1 dose should be administrated as a Direct Observation therapy(DOT)
Remind the patient to complete the treatment.
Advice the patient to sleep under a long lasting insecticidal net to prevent Malaria attack
Note
The dose chart is only applicable for:
Blister 1: adult blister
Artesunate 100 and sulfadoxin +Pyrimthamine 500mg+25mg TABLET
Blister 2 Children Blister
Artesunate 50 mg and Sulfadoxin + Pyrimethamine 500 mg + 25 mg TABLET
Treatment of P. vivax malaria:
Chloroquine (150mg base tablet)
Age
(years)
|
Weight
(kg)
|
DAY 1
(no. of tablets)
|
DAY 2
(no. of tablets)
|
DAY 3
(no. of tablets)
|
<1
|
<10
|
½
|
½
|
½
|
1-<3
|
10-<14
|
1
|
1
|
½
|
3 –< 5
|
14-19
|
1 ½
|
1 ½
|
½
|
5-11
|
20-35
|
2 ½
|
2 ½
|
1
|
11-12
|
36-50
|
3
|
3
|
2
|
14+
|
50+
|
4
|
4
|
2
|
(Source: Revised National Treatment Guideline, April, 2010)
Treatment of mix infection: Treat as Pf malaria.
Malaria Flow Chart At Health Post Level
Registration of the patient
Use RDT
RDT positive (Pf/PAN)
RDT negative
Patient Stable.
Treat the patient
Patient with danger sign
Refer to health facility
Children less than 5 month.
Refer to health facility
Pregnant women (1st trimester)
Refer to health facility
Treat the patient as usual according to CHWs guideline
If Pf positive treat with ACT
If both Pf & PAN positive treat with ACT
If only PAN positive treat with Chloroquin-e
Pregnant women (2nd & 3rd trimester) If only PAN positive treat with Chloroquine
Pregnant women (2nd & 3rd trimester) If only Pf or both Pf & PAN positive treat with ACT
Patient comes back with symptoms after treatment
Refer the patient to the nearest health facility
Chapter five:
Session 1: WELCOME and INTRODUCTION
During this session, the participants will:
Register
Introduce each other
Share their expectations of the training
Introduce with the rules & norms of the training
Undertake a pre-test
Introduce about goal & objectives of the training
Know about the general information of malaria
Objective:
At the end of the session the participants will be able to
Define malaria
Describe signs & symptoms of malaria
Identify the causative agent of malaria
Name the vector of malaria
Describe the mode of transmission of malaria
List the main malaria prevention methods.
Method:
Question and answer
Pictorial presentation
Lecture with discussion
Topics:
General Information about malaria
What is malaria
Signs & Symptoms of malaria
Causative agent of malaria
Vector of malaria
Mode of transmission of malaria
Prevention of malaria
Materials:
Posters/ Pictures
Flip Chart
Session 2: Introduction of Rapid Diagnostic Test
Objective:
At the end of the session the participants will able to
Know what is RDT
Describe advantages & disadvantages of RDT
Use RDT to diagnose malaria
Store RDT at health post level
Methods:
Demonstration of RDT
Question and answer
Topics:
What is RDT
Advantage and disadvantage of RDT
Procedure of RDT use
Storage of RDT
Materials:
RDT Kits
Pictorial instruction about RDT use
Safety box
Register form
Session3: Practical use of RDT
Objective:
At the end of the session the participants will able to
Collect patient’s blood for RDT
Use RDT for diagnosis of malaria
Interpret the result of RDT
Method:
Practical group work
Practical use of RDT
Topic:
Technique of blood collection from patient’s finger
Use of RDT for malaria diagnosis
Interpretation of the result of RDT
Material:
RDT
Lancet
Alcohol swab
Buffer
Dropper
Pictorial instruction about RDT use
Timer/ Watch
Session 4: Management of malaria
Objective:
At the end of the session the participants will able to
Define ACT
Treat the falciparum malaria cases by using ACT
Methods:
Lecture with discussion
Demonstration of ACT
Role play
Topics:
Introduction of ACT
Treatment of malaria by using ACT
Materials:
ACT (Dosage forms)
Pictorial demonstration of ACT, Dosage & treatment
Session 5: Reporting on RDT, ACT & malaria cases
Objective:
At the end of the session the participants will able to
Report on used RDT, positive & negative RDT
Report on ACT use
Report on malaria cases
Methods:
Demonstration of reporting formats
Small group discussion
Topics:
Reporting system about RDT
Reporting system about ACT use
Reporting system about malaria cases
Materials:
Different kinds of reporting formats
Session 6: Reporting on RDT, ACT & malaria cases
Methods:
Question and answer
Discussion
Topics:
Review of the previous lessons
Post test
End evaluation of course
Materials:
Post test sheet
Course evaluation sheet
14>3>10>1>
Share with your friends: |